APO Research

APO RESEARCH · REPORT

CT Image-Assisted Triage and Evaluation Software for Pneumonia

Selected research

Market Analysis & Forecast

Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Analysis and Forecast 2026-2032

Market perspective

The global CT Image-Assisted Triage and Evaluation Software for Pneumonia market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for CT Image-Assisted Triage and Evaluation Software for Pneumonia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CT Image-Assisted Triage and Evaluation Software for Pneumonia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CT Image-Assisted Triage and Evaluation Software for Pneumonia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CT Image-Assisted Triage and Evaluation Software for Pneumonia is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of CT Image-Assisted Triage and Evaluation Software for Pneumonia include Deepwise, Shukun Technology, Infervision Medical, United-Imaging, BioMind, Yizhun Intelligent and Fosun Aitrox, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for CT Image-Assisted Triage and Evaluation Software for Pneumonia, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CT Image-Assisted Triage and Evaluation Software for Pneumonia, also provides the revenue of main regions and countries. Of the upcoming market potential for CT Image-Assisted Triage and Evaluation Software for Pneumonia, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CT Image-Assisted Triage and Evaluation Software for Pneumonia revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CT Image-Assisted Triage and Evaluation Software for Pneumonia market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for CT Image-Assisted Triage and Evaluation Software for Pneumonia revenue, projected growth trends, production technology, application and end-user industry.

CT Image-Assisted Triage and Evaluation Software for Pneumonia Segment by Company

Deepwise

Shukun Technology

Infervision Medical

United-Imaging

BioMind

Yizhun Intelligent

Fosun Aitrox

CT Image-Assisted Triage and Evaluation Software for Pneumonia Segment by Type

Cloud-Based

On-Premise

CT Image-Assisted Triage and Evaluation Software for Pneumonia Segment by Application

Hospital

Clinic

CT Image-Assisted Triage and Evaluation Software for Pneumonia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CT Image-Assisted Triage and Evaluation Software for Pneumonia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CT Image-Assisted Triage and Evaluation Software for Pneumonia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CT Image-Assisted Triage and Evaluation Software for Pneumonia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of CT Image-Assisted Triage and Evaluation Software for Pneumonia in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of CT Image-Assisted Triage and Evaluation Software for Pneumonia company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CT Image-Assisted Triage and Evaluation Software for Pneumonia revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-Based Major Player Table 3. On-Premise Major Player Table 4. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Trends Table 8. CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Drivers Table 9. CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Opportunities and Challenges Table 10. CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Restraints Table 11. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Region (2021-2026) & (US$ Million) Table 13. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Share by Region (2021-2026) Table 14. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Region (2027-2032) & (US$ Million) Table 15. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Share by Region (2027-2032) Table 16. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Players (US$ Million) & (2021-2026) Table 17. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Players (2021-2026) Table 18. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Key Players Headquarters & Area Served Table 20. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Players, Product Type & Application Table 21. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026) & (US$ Million) Table 26. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032) & (US$ Million) Table 27. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Type (2021-2026) Table 28. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Type (2027-2032) Table 29. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026) & (US$ Million) Table 31. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032) & (US$ Million) Table 32. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Application (2021-2026) Table 33. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Application (2027-2032) Table 34. Deepwise Company Information Table 35. Deepwise Business Overview Table 36. Deepwise CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Deepwise CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 38. Deepwise Recent Development Table 39. Shukun Technology Company Information Table 40. Shukun Technology Business Overview Table 41. Shukun Technology CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Shukun Technology CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 43. Shukun Technology Recent Development Table 44. Infervision Medical Company Information Table 45. Infervision Medical Business Overview Table 46. Infervision Medical CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Infervision Medical CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 48. Infervision Medical Recent Development Table 49. United-Imaging Company Information Table 50. United-Imaging Business Overview Table 51. United-Imaging CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. United-Imaging CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 53. United-Imaging Recent Development Table 54. BioMind Company Information Table 55. BioMind Business Overview Table 56. BioMind CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. BioMind CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 58. BioMind Recent Development Table 59. Yizhun Intelligent Company Information Table 60. Yizhun Intelligent Business Overview Table 61. Yizhun Intelligent CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Yizhun Intelligent CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 63. Yizhun Intelligent Recent Development Table 64. Fosun Aitrox Company Information Table 65. Fosun Aitrox Business Overview Table 66. Fosun Aitrox CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Fosun Aitrox CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio Table 68. Fosun Aitrox Recent Development Table 69. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026) & (US$ Million) Table 70. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032) & (US$ Million) Table 71. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026) & (US$ Million) Table 72. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032) & (US$ Million) Table 73. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026) & (US$ Million) Table 75. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (US$ Million) & (2027-2032) Table 83. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026) & (US$ Million) Table 84. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032) & (US$ Million) Table 85. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026) & (US$ Million) Table 86. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. CT Image-Assisted Triage and Evaluation Software for Pneumonia Image Figure 2. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-Based Image Figure 5. On-Premise Image Figure 6. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size (US$ Million) & (2021-2032) Figure 11. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Type (2021-2032) Figure 18. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Application (2021-2032) Figure 21. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032) Figure 23. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032) Figure 24. North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Country (2021-2032) Figure 25. United States CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032) Figure 30. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032) Figure 31. Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Country (2021-2032) Figure 32. Germany CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032) Figure 42. China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032) Figure 43. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032) Figure 45. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032) Figure 46. Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Region (2021-2032) Figure 47. Japan CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032) Figure 55. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032) Figure 56. SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Country (2021-2032) Figure 57. Brazil CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based
  • On-Premise
Applications
  • Hospital
  • Clinic
Companies covered
  • Deepwise
  • Shukun Technology
  • Infervision Medical
  • United-Imaging
  • BioMind
  • Yizhun Intelligent
  • Fosun Aitrox

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CT Image-Assisted Triage and Evaluation Software for Pneumonia Market by Type
  3. 1.2.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-Based
  5. 1.2.3 On-Premise
  6. 1.3 CT Image-Assisted Triage and Evaluation Software for Pneumonia Market by Application
  7. 1.3.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Dynamics
  1. 2.1 CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Trends
  2. 2.2 CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Drivers
  3. 2.3 CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Opportunities and Challenges
  4. 2.4 CT Image-Assisted Triage and Evaluation Software for Pneumonia Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Perspective (2021-2032)
  2. 3.2 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Growth Trends by Region
  3. 3.2.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Region (2021-2026)
  5. 3.2.3 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Players
  2. 4.1.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Players (2021-2026)
  3. 4.1.2 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Key Players Headquarters & Area Served
  7. 4.4 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Players, Product Type & Application
  8. 4.5 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Market CR5 and HHI
  11. 4.6.3 2025 CT Image-Assisted Triage and Evaluation Software for Pneumonia Tier 1, Tier 2, and Tier 3
5 CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Type
  1. 5.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2032)
  3. 5.3 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Type (2021-2032)
6 CT Image-Assisted Triage and Evaluation Software for Pneumonia Market Size by Application
  1. 6.1 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2032)
  3. 6.3 Global CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Deepwise
  2. 7.1.1 Deepwise Company Information
  3. 7.1.2 Deepwise Business Overview
  4. 7.1.3 Deepwise CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Deepwise CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  6. 7.1.5 Deepwise Recent Developments
  7. 7.2 Shukun Technology
  8. 7.2.1 Shukun Technology Company Information
  9. 7.2.2 Shukun Technology Business Overview
  10. 7.2.3 Shukun Technology CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Shukun Technology CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  12. 7.2.5 Shukun Technology Recent Developments
  13. 7.3 Infervision Medical
  14. 7.3.1 Infervision Medical Company Information
  15. 7.3.2 Infervision Medical Business Overview
  16. 7.3.3 Infervision Medical CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Infervision Medical CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  18. 7.3.5 Infervision Medical Recent Developments
  19. 7.4 United-Imaging
  20. 7.4.1 United-Imaging Company Information
  21. 7.4.2 United-Imaging Business Overview
  22. 7.4.3 United-Imaging CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  23. 7.4.4 United-Imaging CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  24. 7.4.5 United-Imaging Recent Developments
  25. 7.5 BioMind
  26. 7.5.1 BioMind Company Information
  27. 7.5.2 BioMind Business Overview
  28. 7.5.3 BioMind CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BioMind CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  30. 7.5.5 BioMind Recent Developments
  31. 7.6 Yizhun Intelligent
  32. 7.6.1 Yizhun Intelligent Company Information
  33. 7.6.2 Yizhun Intelligent Business Overview
  34. 7.6.3 Yizhun Intelligent CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Yizhun Intelligent CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  36. 7.6.5 Yizhun Intelligent Recent Developments
  37. 7.7 Fosun Aitrox
  38. 7.7.1 Fosun Aitrox Company Information
  39. 7.7.2 Fosun Aitrox Business Overview
  40. 7.7.3 Fosun Aitrox CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Fosun Aitrox CT Image-Assisted Triage and Evaluation Software for Pneumonia Product Portfolio
  42. 7.7.5 Fosun Aitrox Recent Developments
8 North America
  1. 8.1 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue (2021-2032)
  2. 8.2 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2032)
  3. 8.2.1 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026)
  4. 8.2.2 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032)
  5. 8.3 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032)
  6. 8.4 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2032)
  7. 8.4.1 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026)
  8. 8.4.2 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032)
  9. 8.5 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032)
  10. 8.6 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country
  11. 8.6.1 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026)
  13. 8.6.3 North America CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue (2021-2032)
  2. 9.2 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2032)
  3. 9.2.1 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026)
  4. 9.2.2 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032)
  5. 9.3 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032)
  6. 9.4 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2032)
  7. 9.4.1 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026)
  8. 9.4.2 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032)
  9. 9.5 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032)
  10. 9.6 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country
  11. 9.6.1 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026)
  13. 9.6.3 Europe CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue (2021-2032)
  2. 10.2 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2032)
  3. 10.2.1 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026)
  4. 10.2.2 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032)
  5. 10.3 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032)
  6. 10.4 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2032)
  7. 10.4.1 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026)
  8. 10.4.2 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032)
  9. 10.5 China CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue (2021-2032)
  2. 11.2 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2032)
  3. 11.2.1 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026)
  4. 11.2.2 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032)
  5. 11.3 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032)
  6. 11.4 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2032)
  7. 11.4.1 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026)
  8. 11.4.2 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032)
  9. 11.5 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032)
  10. 11.6 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country
  11. 11.6.1 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026)
  13. 11.6.3 Asia CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue (2021-2032)
  2. 12.2 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Type (2027-2032)
  5. 12.3 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Application (2027-2032)
  9. 12.5 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country
  11. 12.6.1 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA CT Image-Assisted Triage and Evaluation Software for Pneumonia Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research